HSDT - Helius Medical Technologies, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Helius Medical Technologies, Inc.

642 Newtown Yardley Road
Suite 100
Newtown, PA 18940
United States

IndustryMedical Devices
Full Time Employees25

Key Executives

NameTitlePayExercisedYear Born
Mr. Philippe DeschampsChairman, CEO & Pres673.44kN/A1962
Ms. Joyce N. LaViscountCFO & COO489.39kN/A1962
Dr. Jonathan Mark SackierChief Medical OfficerN/AN/A1958
Diane CarmanSec.N/AN/AN/A
Dr. Brian W. Bapty Ph.D.VP of Strategy and Bus. Devel.N/AN/A1969
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.

Corporate Governance

Helius Medical Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.